Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV000626571 | SCV000747272 | likely pathogenic | Splenomegaly | 2017-01-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001051234 | SCV001215378 | likely pathogenic | Autoimmune lymphoproliferative syndrome type 1 | 2022-01-19 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FAS protein function. ClinVar contains an entry for this variant (Variation ID: 523313). This missense change has been observed in individual(s) with autoimmune lymphoproliferative syndrome (ALPS) (Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 179 of the FAS protein (p.Leu179Arg). |
Ce |
RCV001815421 | SCV002062932 | uncertain significance | not provided | 2021-10-01 | criteria provided, single submitter | clinical testing |